losartan and deoxyglucose

losartan has been researched along with deoxyglucose in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ebina, Y; Houchi, H; Ishizawa, K; Kishi, K; Minakuchi, K; Nakaya, Y; Takishita, E; Tamaki, T; Tsuchiya, K; Yoshizumi, M1
Han, HJ; Heo, JS; Lee, YJ1

Other Studies

2 other study(ies) available for losartan and deoxyglucose

ArticleYear
Effects of losartan in combination with or without exercise on insulin resistance in Otsuka Long-Evans Tokushima Fatty rats.
    European journal of pharmacology, 2001, Nov-02, Volume: 430, Issue:2-3

    Topics: Adipocytes; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Blotting, Western; Body Weight; Deoxyglucose; Diabetes Mellitus, Type 2; Enzyme Activation; Glucose; Glucose Tolerance Test; Glucose Transporter Type 4; Heart Rate; Insulin; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Losartan; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Physical Conditioning, Animal; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred OLETF

2001
ANG II increases 2-deoxyglucose uptake in mouse embryonic stem cells.
    Life sciences, 2005, Aug-26, Volume: 77, Issue:15

    Topics: Alkaline Phosphatase; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biological Transport; Calcimycin; Calcium; Cell Line; Cell Proliferation; Deoxyglucose; DNA-Binding Proteins; Dose-Response Relationship, Drug; Embryo, Mammalian; Estrenes; Gene Expression; Glucose Transporter Type 1; Imidazoles; Inositol Phosphates; Losartan; Membrane Transport Proteins; Mice; Monosaccharide Transport Proteins; Neomycin; Octamer Transcription Factor-3; Phosphodiesterase Inhibitors; Protein Kinase C; Pyridines; Pyrrolidinones; Stem Cells; Transcription Factors; Type C Phospholipases; Vasoconstrictor Agents

2005